Fundraising Fox

Vesica Health

Irvine, US · Founded 2022 · Delaware corporation

Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.

Founders & leadership

CTChristopher Thibodeau
Christopher ThibodeauExecutive
LCLaura Caba
Laura CabaExecutive

Board

JG
Jan GroenBoard director
MM
Mark McDonoughBoard director
JS
Joseph SolleeBoard director

Reported raises · per SEC filings

Form D private placements

$4.5M disclosed across 1 round · 2026

$4.5MraisedMar 2026 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher ThibodeauExecutive Officer, Director
  • Jan GroenDirector
  • Mark McDonoughDirector
  • Joseph SolleeDirector
  • Laura CabaExecutive Officer
Offering amount
$4.6M
Amount sold
$4.5M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Vesica Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Vesica Health do?
Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.
How much funding has Vesica Health raised?
Vesica Health has disclosed $4.5M raised across 1 round.
Where is Vesica Health headquartered?
Vesica Health is headquartered in Irvine, US.